Morphological, clinical and genetic aspects in a family with a novel LAMP-2 gene mutation (Danon disease)

被引:34
作者
Lobrinus, JA
Schorderet, DF
Payot, M
Jeanrenaud, X
Bottani, A
Superti-Furga, A
Schlaepfer, J
Fromer, M
Jeannet, PY [1 ]
机构
[1] CHU Vaudois, Serv Pediat, Unite Neuropediat, CH-1011 Lausanne, Switzerland
[2] CHU Vaudois, Inst Pathol, Div Neuropathol, CH-1011 Lausanne, Switzerland
[3] IRO, CH-1950 Sion, Switzerland
[4] CHU Vaudois, Serv Pediat, Unite Cardiol, CH-1011 Lausanne, Switzerland
[5] CHU Vaudois, Serv Cardiol, CH-1011 Lausanne, Switzerland
[6] Hop Univ Geneve, Div Med Genet, CH-1211 Geneva, Switzerland
[7] CHU Vaudois, Serv Pediat, Div Pediat Mol, CH-1011 Lausanne, Switzerland
关键词
Danon disease; LAMP-2; immunohistochemistry; cardiomyopathy; myopathy; morphology; genetic;
D O I
10.1016/j.nmd.2004.12.007
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
A family with several cases of severe cardiomyopathy and moderate myopathy is described, affecting two brothers and their cousin as well as their mothers. One boy died of sudden cardiac arrest at 17 years of age. The two brothers were treated with an implantable defibrillator and their mother died suddenly at 40 years of age. Muscle biopsy in males showed vacuolar myopathy in two cases, and no abnormality on standard staining in the third case. Cardiac biopsies showed hypertrophic and vacuolated fibres. Complete absence of LAMP-2 was demonstrated by immunohistochemistry on the vacuolated skeletal and cardiac muscle, but also on the morphologically normal skeletal muscle. Sequencing of LAMP-2 gene showed a novel S157X mutation in exon 4. Danon disease is a rare and potentially lethal cause of hypertrophic cardiomyopathy. Diagnosis can be made by immunohistochemistry performed on cardiac or muscle biopsy, and confirmed by genetic analysis, which also allows for easy family screening and counselling. (c) 2005 Elsevier B.V. All rights reserved.
引用
收藏
页码:293 / 298
页数:6
相关论文
共 19 条
[1]
Hypertrophic cardiomyopathy: a paradigm for myocardial energy depletion [J].
Ashrafian, H ;
Redwood, C ;
Blair, E ;
Watkins, H .
TRENDS IN GENETICS, 2003, 19 (05) :263-268
[2]
Hypertrophic cardiomyopathy due to sarcomeric gene mutations is characterized by impaired energy metabolism irrespective of the degree of hypertrophy [J].
Crilley, JG ;
Boehm, EA ;
Blair, E ;
Rajagopalan, B ;
Blamire, AM ;
Styles, P ;
McKenna, WJ ;
Östman-Smith, I ;
Clarke, K ;
Watkins, H .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 41 (10) :1776-1782
[3]
LYSOSOMAL GLYCOGEN-STORAGE DISEASE WITH NORMAL ACID MALTASE [J].
DANON, MJ ;
OH, SJ ;
DIMAURO, S ;
MANALIGOD, JR ;
EASTWOOD, A ;
NAIDU, S ;
SCHLISELFELD, LH .
NEUROLOGY, 1981, 31 (01) :51-57
[4]
RAPID EXAMINATION OF MUSCLE TISSUE - AN IMPROVED TRICHROME METHOD FOR FRESH-FROZEN BIOPSY SECTIONS [J].
ENGEL, WK ;
CUNNINGHAM, GG .
NEUROLOGY, 1963, 13 (11) :919-&
[5]
FUKADA M, 1994, SUBCEL BIOCH, V22, P199
[6]
Horváth J, 2003, NEUROPEDIATRICS, V34, P270
[7]
Danon's disease (X-linked vacuolar cardiomyopathy and myopathy):: a case with a novel Lamp-2 gene mutation [J].
Lacoste-Collin, L ;
Garcia, V ;
Uro-Coste, E ;
Arné-Bes, MC ;
Durand, D ;
Levade, T ;
Delisle, MB .
NEUROMUSCULAR DISORDERS, 2002, 12 (09) :882-885
[8]
Deficit of in vivo mitochondrial ATP production in patients with Friedreich ataxia [J].
Lodi, R ;
Cooper, JM ;
Bradley, JL ;
Manners, D ;
Styles, P ;
Taylor, DJ ;
Schapira, AHV .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (20) :11492-11495
[9]
Marian A J, 2001, Minerva Med, V92, P435
[10]
Hypertrophic cardiomyopathy - A systematic review [J].
Maron, BJ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 287 (10) :1308-1320